Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...

Please provide your email address to receive an email when new articles are posted on . After corneal refractive surgery, patients need careful evaluation when receiving a presbyopia-correcting IOL.

“We are excited to introduce Vivity because it addresses some common concerns of surgeons and cataract patients alike when considering presbyopia-correcting IOLs (PC-IOLs),” said Michael Onuscheck, ...

Clareon Vivity is the first and only non-diffractive extended depth of focus (EDOF) IOL with the wavefront-shaping X-WAVE Technology on Alcon’s most advanced lens platform1-6 Clareon Vivity joins ...

Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...

The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received European CE Mark for its AcrySof IQ PanOptix trifocal intraocular lens (IOL) for patients ...

Because of the increasing prevalence and increased interest in reduced dependence on spectacles for reading, novel options continue to emerge. The traditional approach of blended vision with either ...

Patients who have a new type of lens implanted in their eyes during surgery for cataracts or to correct their eyesight have excellent or good vision over distances both near and far, and often no ...

The "Presbyopia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global ...